Using the representatives of CD8+ T cells, TAMs, and NK cells, we profiled the spatial distribution of infiltrating immune cells and depicted a heterogeneous TME landscape for stage IA NSCLC. This evidence concerns the gene CD8A and non-small cell lung carcinoma.